We are live on
!
Find out more
AQR Capital Management Portfolio holdings
AUM
$218B
1-Year Est. Return
29.41%
This Fund
S&P 500
This Quarter
Est. Return
-12.77%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$44.2B
AUM Growth
-$8.44B
(-16%)
Cap. Flow
-$301M
Cap. Flow
% of AUM
-0.68%
Top 10 Holdings %
Top 10 Hldgs %
14.01%
Holding
2,360
New
150
Increased
1,005
Reduced
998
Closed
187
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$209M |
| 2 |
CVS Health
CVS
|
+$195M |
| 3 |
Tyson Foods
TSN
|
+$136M |
| 4 |
ExxonMobil
XOM
|
+$135M |
| 5 |
LyondellBasell Industries
LYB
|
+$130M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$239M |
| 2 |
Microsoft
MSFT
|
+$204M |
| 3 |
Johnson & Johnson
JNJ
|
+$157M |
| 4 |
Amazon
AMZN
|
+$144M |
| 5 |
Walmart Inc
WMT
|
+$137M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.23% |
| 2 | Healthcare | 16.49% |
| 3 | Financials | 11.74% |
| 4 | Industrials | 11.47% |
| 5 | Consumer Discretionary | 10.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
801
First Financial Corp
THFF
$967M
| $5.04M | 0.01% |
113,341
+28,610
| +34% | +$1.25M |
|
802
AMN Healthcare
AMN
$1.28B
| $5.03M | 0.01% |
45,844
+9,799
| +27% | +$970K |
|
803
REX American Resources
REX
$1.43B
| $5M | 0.01% |
354,000
+229,422
| +184% | +$3.38M |
|
804
M&T Bank
MTB
$36.4B
| $4.99M | 0.01% |
31,882
-109,188
| -77% | -$18.3M |
|
805
Invitation Homes
INVH
$17.7B
| $4.95M | 0.01% |
140,289
-46,280
| -25% | -$1.76M |
|
806
Toro Company
TTC
$9.41B
| $4.93M | 0.01% |
65,700
-101,423
| -61% | -$8.23M |
|
807
PROG Holdings
PRG
$1.66B
| $4.93M | 0.01% |
307,280
+71,044
| +30% | +$1.82M |
|
808
Northern Trust
NTRS
$34.4B
| $4.92M | 0.01% |
51,364
-76,728
| -60% | -$8.11M |
|
|
DOC
809
DELISTED
PHYSICIANS REALTY TRUST
DOC
| $4.91M | 0.01% |
281,123
-256,362
| -48% | -$4.53M |
|
810
Entergy
ETR
$49.7B
| $4.88M | 0.01% |
86,890
-15,318
| -15% | -$901K |
|
811
Crocs
CROX
$6.31B
| $4.88M | 0.01% |
104,254
-427,819
| -80% | -$26M |
|
812
Wendy's
WEN
$1.44B
| $4.88M | 0.01% |
260,921
-325,940
| -56% | -$6.18M |
|
|
STOR
813
DELISTED
STORE Capital Corporation
STOR
| $4.87M | 0.01% |
186,805
+152,722
| +448% | +$4.23M |
|
814
Datadog
DDOG
$88.6B
| $4.79M | 0.01% |
51,917
+39,357
| +313% | +$4.33M |
|
815
TJX Companies
TJX
$172B
| $4.79M | 0.01% |
85,795
+24,553
| +40% | +$1.49M |
|
816
Regions Financial
RF
$26.9B
| $4.79M | 0.01% |
260,776
-63,155
| -19% | -$1.3M |
|
817
America Movil
AMX
$70.3B
| $4.77M | 0.01% |
233,411
-269,882
| -54% | -$5.55M |
|
818
Allegro MicroSystems
ALGM
$7.93B
| $4.77M | 0.01% |
233,509
+32,460
| +16% | +$775K |
|
819
MongoDB
MDB
$35.3B
| $4.76M | 0.01% |
18,487
+4,351
| +31% | +$1.36M |
|
820
News Corp Class A
NWSA
$15.5B
| $4.75M | 0.01% |
313,648
+106,237
| +51% | +$1.95M |
|
821
Constellation Brands
STZ
$22.9B
| $4.72M | 0.01% |
20,292
-9,493
| -32% | -$2.31M |
|
822
SLM Corp
SLM
$5.11B
| $4.66M | 0.01% |
300,249
-1,077,639
| -78% | -$18.7M |
|
823
Ingles Markets
IMKTA
$1.65B
| $4.61M | 0.01% |
53,176
-397
| -0.7% | -$36.1K |
|
824
TransDigm Group
TDG
$68.7B
| $4.61M | 0.01% |
8,911
+5,929
| +199% | +$3.5M |
|
825
EastGroup Properties
EGP
$10.8B
| $4.6M | 0.01% |
29,905
+3,519
| +13% | +$617K |
|
Similar funds
VGA
AQR Capital Management's Q2 2022 Portfolio in Review
As of Q2 2022, AQR Capital Management held 2,360 positions worth $44.2B, down 16% from $52.7B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
AQR Capital Management's Q2 2022 filing shows 150 new, 1,005 increased, 998 reduced and 187 closed positions. Its largest new stake was Fluor: 339,891 shares worth $7.86M. The largest sale was Thermo Fisher Scientific, an estimated $239M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
- AQR Capital Management's largest Q2 2022 buy was Fluor: 339,891 shares worth $7.86M.
- AQR Capital Management added most to Gilead Sciences in Q2 2022, an estimated $209M increase.
- AQR Capital Management's biggest Q2 2022 reduction was Thermo Fisher Scientific, cutting an estimated $239M.
- AQR Capital Management fully exited Roku in Q2 2022, selling an estimated $32.5M.
- AQR Capital Management's ten largest holdings make up 14% of its $44.2B portfolio in Q2 2022.
- AQR Capital Management opened 150 new positions and closed 187 in Q2 2022.
- AQR Capital Management's portfolio value fell 16% quarter-over-quarter to $44.2B.
Based on AQR Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.